Digicann Ventures Inc (AGFAF)
0.011
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Digicann Ventures 1 Year Total Returns (Daily): -89.00% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -89.00% |
May 02, 2024 | -88.00% |
May 01, 2024 | -91.43% |
April 30, 2024 | -92.60% |
April 29, 2024 | -92.60% |
April 26, 2024 | -91.12% |
April 25, 2024 | -92.60% |
April 24, 2024 | -91.46% |
April 23, 2024 | -92.00% |
April 22, 2024 | -92.00% |
April 19, 2024 | -94.25% |
April 18, 2024 | -90.00% |
April 17, 2024 | -91.24% |
April 16, 2024 | -90.91% |
April 15, 2024 | -90.91% |
April 12, 2024 | -88.32% |
April 11, 2024 | -86.67% |
April 10, 2024 | -91.24% |
April 09, 2024 | -90.32% |
April 08, 2024 | -90.32% |
April 05, 2024 | -90.56% |
April 04, 2024 | -90.19% |
April 03, 2024 | -90.93% |
April 02, 2024 | -92.05% |
April 01, 2024 | -92.05% |
Date | Value |
---|---|
March 28, 2024 | -88.41% |
March 27, 2024 | -91.17% |
March 26, 2024 | -91.88% |
March 25, 2024 | -91.88% |
March 22, 2024 | -89.82% |
March 21, 2024 | -90.24% |
March 20, 2024 | -89.11% |
March 19, 2024 | -87.93% |
March 18, 2024 | -87.93% |
March 15, 2024 | -87.93% |
March 14, 2024 | -87.93% |
March 13, 2024 | -87.73% |
March 12, 2024 | -90.86% |
March 11, 2024 | -89.49% |
March 08, 2024 | -90.44% |
March 07, 2024 | -91.44% |
March 06, 2024 | -89.49% |
March 05, 2024 | -92.64% |
March 04, 2024 | -92.62% |
March 01, 2024 | -92.02% |
February 29, 2024 | -91.98% |
February 28, 2024 | -91.98% |
February 27, 2024 | -91.47% |
February 26, 2024 | -92.00% |
February 23, 2024 | -91.39% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.55%
Minimum
Sep 08 2022
251.7%
Maximum
May 07 2019
-59.32%
Average
-87.93%
Median
Mar 14 2024
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 10.17% |
Aurinia Pharmaceuticals Inc | -56.37% |
Edesa Biotech Inc | -40.91% |
Lexaria Bioscience Corp | 93.21% |
Xenon Pharmaceuticals Inc | 7.28% |